SYDNEY & AUCKLAND, New Zealand--(BUSINESS WIRE)--Living Cell Technologies Limited (ASX:LCT) (OTCQX:LVCLY) announced today the quarterly cash flow report for the quarter ended 31 March 2010. The Appendix 4C is attached. The cash balance at the end of the quarter was $4,090,696 compared to $5,494,841 at 31 December 2009. This decrease reflects the development of the lead product DIABECELL®.
